PCN68 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
May 1, 2010, 00:00
10.1016/S1098-3015(10)72157-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)72157-4/fulltext
Title :
PCN68 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72157-4&doi=10.1016/S1098-3015(10)72157-4
First page :
Section Title :
Open access? :
No
Section Order :
739